作者投稿
专家审稿
编辑办公
邮件订阅
RSS
-
摘要: 硼中子俘获疗法(Boron neutron capture therapy, BNCT)是一项处于快速发展中的先进放疗技术。该技术通过在癌细胞内发生的10B(n, α)7Li原子核反应杀死癌细胞，是一种原子级别的二元靶向治疗，其临床实施需要专业技术与装置支持。BNCT的核心要素包括适宜的中子源及中子俘获药物。相较于传统放疗技术，BNCT在治疗局部复发肿瘤(如中枢神经系统肿瘤和头颈部肿瘤)中优势突出，能够更好地保护正常器官，特别是对于已经对周围器官产生明显侵犯的肿瘤具有良好的应用前景。本文主要阐述BNCT的技术原理、核心要素及其临床应用，以期为临床诊疗提供参考。Abstract: Boron neutron capture therapy (BNCT) is an advanced radiation therapy technique that is rapidly developing in the field of cancer treatment. This technique, an atomic-level binary targeted therapy, kills cancer cells by causing a 10B(n, α)7Li nuclear reaction within the cancer cells, and its clinical implementation requires professional technology and device support. The core elements of BNCT include appropriate neutron sources and neutron capture drugs. Compared with traditional radiotherapy techniques, BNCT shows outstanding advantages in treating locally recurrent tumors, such as central nervous system tumors and head and neck tumors. Furthermore, it can better protect normal organs, especially for tumors that have already significantly invaded surrounding organs, demonstrating its promising future prospects. This article mainly elaborates on the technical principles, core elements, and clinical applications of BNCT, in hope of providing reference for clinical diagnosis and treatment.作者贡献：刘志凯负责设计论文框架，调研整理文献，撰写论文初稿及修订论文；程炜诗负责调研整理文献，参与撰写论文初稿及论文修订；吴王锁、梁天骄、邢庆子、张紫竹、刘志博、刘渊豪、潘建基、朱晒红、李晴暖、张福泉、邱杰负责调研整理文献；霍力负责指导修订、审核论文。利益冲突：所有作者均声明不存在利益冲突
-
[1] Taylor HJ, Goldhaber M. Detection of Nuclear Disintegration in a Photographic Emulsion[J]. Nature, 1935, 135: 341. [2] 关兴彩. 0.5eV到数百keV能区中子通量密度监测器的理论设计与实验研究[D]. 兰州: 兰州大学, 2016. [3] Kankaanranta L, Seppälä T, Koivunoro H, et al. Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase Ⅰ/Ⅱ trial[J]. Int J Radiat Oncol Biol Phys, 2012, 82: e67-e75. doi: 10.1016/j.ijrobp.2010.09.057 [4] Kasesaz Y, Khalafi H, Rahmani F. Optimization of the beam shaping assembly in the D-D neutron generators-based BNCT using the response matrix method[J]. Appl Radiat Isot, 2013, 82: 55-59. doi: 10.1016/j.apradiso.2013.07.008 [5] Kasesaz Y, Rahmani F, Khalafi H. Investigation on the reflector/moderator geometry and its effect on the neutron beam design in BNCT[J]. Appl Radiat Isot, 2015, 106: 34-37. doi: 10.1016/j.apradiso.2015.08.012 [6] Barth RF, Vicente MGH, Harling OK, et al. Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer[J]. Radiat Oncol, 2012, 7: 146. doi: 10.1186/1748-717X-7-146 [7] Kasesaz Y, Khalafi H, Rahmani F, et al. A feasibility study of the Tehran research reactor as a neutron source for BNCT[J]. Appl Radiat Isot, 2014, 90: 132-137. doi: 10.1016/j.apradiso.2014.03.028 [8] Durisi E, Alikaniotis K, Borla O, et al. Design and simulation of an optimized e-linac based neutron source for BNCT research[J]. Appl Radiat Isot, 2015, 106: 63-67. doi: 10.1016/j.apradiso.2015.07.039 [9] Rahmani F, Seifi S, Anbaran HT, et al. Design of photon converter and photoneutron target for High power electron accelerator based BNCT[J]. Appl Radiat Isot, 2015, 106: 45-48. doi: 10.1016/j.apradiso.2015.08.008 [10] Skalyga V, Izotov I, Golubev S, et al. Neutron generator for BNCT based on high current ECR ion source with gyrotron plasma heating[J]. Appl Radiat Isot, 2015, 106: 29-33. doi: 10.1016/j.apradiso.2015.08.015 [11] Sumita K, Takahashi A, Iida T, et al. Status of OKTAVIAN Ⅰ and proposal for OKTAVIAN Ⅱ[J]. Nuclear Science and Engineering, 1990, 106: 249-265. doi: 10.13182/NSE90-A29054 [12] Barth RF, Mi P, Yang W. Boron delivery agents for neutron capture therapy of cancer[J]. Cancer Commun (Lond), 2018, 38: 35. doi: 10.1186/s40880-018-0299-7 [13] Hu K, Yang Z, Zhang L, et al. Boron agents for neutron capture therapy[J]. Coordination Chemistry Reviews, 2020, 405: 213139. doi: 10.1016/j.ccr.2019.213139 [14] Farr LE, Sweet WH, Robertson JS, et al. Neutron capture therapy with boron in the treatment of glioblastoma multiforme[J]. Am J Roentgenol Radium Ther Nucl Med, 1954, 71: 279-293. [15] Goodwin JT, Farr LE, Sweet WH, et al. Pathological study of eight patients with glioblastoma multiforme treated by neutron-capture therapy using boron 10[J]. Cancer, 1955, 8: 601-615. doi: 10.1002/1097-0142(1955)8:3<601::AID-CNCR2820080326>3.0.CO;2-R [16] Sweet WH, Javid M. The possible use of neutron-capturing isotopes such as boron 10 in the treatment of neoplasms. Ⅰ. Intracranial tumors[J]. J Neurosurg, 1952, 9: 200-209. doi: 10.3171/jns.1952.9.2.0200 [17] Asbury AK, Ojemann RG, Nielsen SL, et al. Neuropatho-logic study of fourteen cases of malignant brain tumor treated by boron-10 slow neutron capture radiation[J]. J Neuropathol Exp Neurol, 1972, 31: 278-303. doi: 10.1097/00005072-197204000-00005 [18] Mishima Y, Ichihashi M, Hatta S, et al. First human clinical trial of melanoma neutron capture. Diagnosis and therapy[J]. Strahlenther Onkol, 1989, 165: 251-254. [19] Kankaanranta L, Seppälä T, Koivunoro H, et al. L-boronophenylalanine-mediated boron neutron capture therapy for malignant glioma progressing after external beam radiation therapy: a Phase Ⅰ study[J]. Int J Radiat Oncol Biol Phys, 2011, 80: 369-376. doi: 10.1016/j.ijrobp.2010.02.031 [20] Soloway AH, Hatanaka H, Davis MA. Penetration of brain and brain tumor. Ⅶ. Tumor-binding sulfhydryl boron compounds[J]. J Med Chem, 1967, 10: 714-717. doi: 10.1021/jm00316a042 [21] Hatanaka H, Nakagawa Y. Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy[J]. Int J Radiat Oncol Biol Phys, 1994, 28: 1061-1066. doi: 10.1016/0360-3016(94)90479-0 [22] Nakagawa Y, Pooh K, Kobayashi T, et al. Clinical review of the Japanese experience with boron neutron capture therapy and a proposed strategy using epithermal neutron beams[J]. J Neurooncol, 2003, 62: 87-99. [23] Evangelista L, Jori G, Martini D, et al. Boron neutron capture therapy and 18F-labelled borophenylalanine positron emission tomography: a critical and clinical overview of the literature[J]. Appl Radiat Isot, 2013, 74: 91-101. doi: 10.1016/j.apradiso.2013.01.001 [24] Ishiwata K. 4-Borono-2-18F-fluoro-L-phenylalanine PET for boron neutron capture therapy-oriented diagnosis: overview of a quarter century of research[J]. Ann Nucl Med, 2019, 33: 223-236. doi: 10.1007/s12149-019-01347-8 [25] 龚春慧. 硼中子俘获治疗中硼浓度在线实时监测系统关键技术研究[D]. 南京: 南京航空航天大学, 2018. [26] Diaz AZ. Assessment of the results from the phase Ⅰ/Ⅱ boron neutron capture therapy trials at the Brookhaven National Laboratory from a clinician's point of view[J]. J Neurooncol, 2003, 62: 101-109. [27] Matsumura A, Yamamoto T, Tsurubuchi T, et al. Current practices and future directions of therapeutic strategy in glioblastoma: survival benefit and indication of BNCT[J]. Appl Radiat Isot, 2009, 67: S12-S14. doi: 10.1016/j.apradiso.2009.03.010 [28] Kageji T, Nagahiro S, Mizobuchi Y, et al. Boron neutron capture therapy (BNCT) for newly-diagnosed glioblastoma: comparison of clinical results obtained with BNCT and conventional treatment[J]. J Med Invest, 2014, 61: 254-263. doi: 10.2152/jmi.61.254 [29] Kawabata S, Miyatake SI, Nonoguchi N, et al. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients[J]. Appl Radiat Isot, 2009, 67: S15-S18. doi: 10.1016/j.apradiso.2009.03.015 [30] Kawabata S, Suzuki M, Hirose K, et al. Accelerator-based BNCT for patients with recurrent glioblastoma: a multicenter phase Ⅱ study[J]. Neurooncol Adv, 2021, 3: vdab067. [31] Takeuchi K, Kawabata S, Hiramatsu R, et al. Boron Neutron Capture Therapy for High-Grade Skull-Base Meningioma[J]. J Neurol Surg B Skull Base, 2018, 79: S322-S327. doi: 10.1055/s-0038-1666837 [32] Suzuki M, Kato I, Aihara T, et al. Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer[J]. J Radiat Res, 2014, 55: 146-153. doi: 10.1093/jrr/rrt098 [33] Kato I, Fujita Y, Maruhashi A, et al. Effectiveness of boron neutron capture therapy for recurrent head and neck malignancies[J]. Appl Radiat Isot, 2009, 67: S37-S42. doi: 10.1016/j.apradiso.2009.03.103 [34] Kato T, Hirose K, Tanaka H, et al. Design and construction of an accelerator-based boron neutron capture therapy (AB-BNCT) facility with multiple treatment rooms at the Southern Tohoku BNCT Research Center[J]. Appl Radiat Isot, 2020, 156: 108961. doi: 10.1016/j.apradiso.2019.108961 [35] Menéndez PR, Roth BMC, Pereira MD, et al. BNCT for skin melanoma in extremities: updated Argentine clinical results[J]. Appl Radiat Isot, 2009, 67: S50-S53. doi: 10.1016/j.apradiso.2009.03.020 [36] Yong Z, Song Z, Zhou Y, et al. Boron neutron capture therapy for malignant melanoma: first clinical case report in China[J]. Chin J Cancer Res, 2016, 28: 634-640. doi: 10.21147/j.issn.1000-9604.2016.06.10 [37] Suzuki M, Endo K, Satoh H, et al. A novel concept of treatment of diffuse or multiple pleural tumors by boron neutron capture therapy (BNCT)[J]. Radiother Oncol, 2008, 88: 192-195. doi: 10.1016/j.radonc.2008.06.009 [38] Seneviratne D, Advani P, Trifiletti DM, et al. Exploring the Biological and Physical Basis of Boron Neutron Capture Therapy (BNCT) as a Promising Treatment Frontier in Breast Cancer[J]. Cancers (Basel), 2022, 14: 3009. doi: 10.3390/cancers14123009 [39] Wei Q, Kullberg EB, Gedda L. Trastuzumab-conjugated boron-containing liposomes for tumor-cell targeting; development and cellular studies[J]. Int J Oncol, 2003, 23: 1159-1165. [40] Gadan MA, González SJ, Batalla M, et al. Application of BNCT to the treatment of HER2+ breast cancer recurrences: Research and developments in Argentina[J]. Appl Radiat Isot, 2015, 104: 155-159. doi: 10.1016/j.apradiso.2015.07.006 [41] Futamura G, Kawabata S, Siba H, et al. A case of radiation-induced osteosarcoma treated effectively by boron neutron capture therapy[J]. Radiat Oncol, 2014, 9: 237. doi: 10.1186/s13014-014-0237-z [42] Fujimoto T, Andoh T, Sudo T, et al. Potential of boron neutron capture therapy (BNCT) for malignant peripheral nerve sheath tumors (MPNST)[J]. Appl Radiat Isot, 2015, 106: 220-225. doi: 10.1016/j.apradiso.2015.07.059 [43] Hiratsuka J, Kamitani N, Tanaka R, et al. Boron neutron capture therapy for vulvar melanoma and genital extramammary Paget's disease with curative responses[J]. Cancer Commun (Lond), 2018, 38: 38. doi: 10.1186/s40880-018-0297-9 [44] Nakagawa Y, Kageji T, Mizobuchi Y, et al. Clinical results of BNCT for malignant brain tumors in children[J]. Appl Radiat Isot, 2009, 67: S27-S30. doi: 10.1016/j.apradiso.2009.03.090 -
下载:
点击查看大图
图(1)
计量
- 文章访问数: 2062
- HTML全文浏览量: 85
- PDF下载量: 203
- 被引次数: 0
